We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

83 hedge funds and large institutions have $718M invested in La Jolla Pharmaceutical Company in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 15 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 15

122% more call options, than puts

Call options by funds: $11.7M | Put options by funds: $5.28M

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

7% more capital invested

Capital invested by funds: $672M → $718M (+$46.1M)

14% less funds holding

Funds holding: 96 → 83 (-13)

40% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 25

Holders
83
Holders Change
-13
Holders Change %
-13.54%
% of All Funds
2.07%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
15
Increased
46
Reduced
15
Closed
25
Calls
$11.7M
Puts
$5.28M
Net Calls
+$6.45M
Net Calls Change
+$6.42M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$24.2M
2
State Street
State Street
Massachusetts
+$23.7M
3
CCM
Consonance Capital Management
New York
+$17M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$14.7M
5
BC
Broadfin Capital
New York
+$13.6M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$24.3M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$8.01M
3
FCM
Farallon Capital Management
California
-$7.69M
4
CLCM
Crawford Lake Capital Management
New Jersey
-$5.12M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$2.21M +$268K +9,347 +14%
Adage Capital Partners
27
Adage Capital Partners
Massachusetts
$2.14M -$5.1M -178,000 -71%
TAM
28
Tocqueville Asset Management
New York
$2.09M +$2.87K +100 +0.1%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$1.87M -$3.57M -124,478 -67%
AI
30
Axiom Investors
Connecticut
$1.65M +$60.7K +2,119 +4%
EU
31
Emory University
Georgia
$1.41M +$1.36M +47,353 New
TCIM
32
TIAA CREF Investment Management
New York
$1.4M +$307K +10,703 +29%
Citigroup
33
Citigroup
New York
$1.31M +$1.2M +41,790 +1,827%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$1.26M – – –
AAM
35
Advisors Asset Management
Colorado
$984K -$95.7K -3,339 -9%
CS
36
Credit Suisse
Switzerland
$956K +$545K +19,017 +145%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$923K +$103K +3,600 +13%
TA
38
Teachers Advisors
New York
$919K +$157K +5,469 +22%
Swiss National Bank
39
Swiss National Bank
Switzerland
$875K – – –
UBS Group
40
UBS Group
Switzerland
$855K +$650K +22,684 +376%
Charles Schwab
41
Charles Schwab
California
$836K +$186K +6,500 +30%
EI
42
EAM Investors
California
$662K -$117K -4,093 -16%
HCM
43
Hollencrest Capital Management
California
$658K – – –
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$596K +$104K +3,618 +22%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$545K +$91.7K +3,199 +21%
LP
46
LMR Partners
United Kingdom
$538K -$1.77M -61,917 -77%
NPC
47
National Planning Corporation
California
$523K -$2.87K -100 -0.6%
AL
48
Airain Ltd
Guernsey
$522K +$502K +17,519 New
CI
49
Cowen Inc
New York
$512K +$493K +17,200 New
AllianceBernstein
50
AllianceBernstein
Tennessee
$509K +$126K +4,400 +35%
1
2
3 4 5

LJPC Hedge Fund Activity: Q2 2017 in Review

83 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q2 2017, worth a combined $718M — up 6.9% from $672M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of LJPC and 15 opened new positions — a net loss of 10 holders — while 15 trimmed existing stakes and 46 added.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $24.2M. The largest seller was Franklin Resources, exiting entirely with an estimated $24.3M sold.

  • 83 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q2 2017, down from 96 in Q1 2017.
  • Funds reported $718M of La Jolla Pharmaceutical Company stock for Q2 2017, up 6.9% quarter-over-quarter.
  • 15 funds opened new La Jolla Pharmaceutical Company positions in Q2 2017 and 25 closed out, a net change of -10 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q2 2017 was Janus Henderson Group, an estimated $24.2M added.
  • The largest La Jolla Pharmaceutical Company seller in Q2 2017 was Franklin Resources, an estimated $24.3M sold.

Based on aggregated 13F filings for Q2 2017.